Beximco Pharmaceuticals Limited Sponsored GDR RegS stock analysis
Beximco Pharmaceuticals Limited Sponsored GDR RegS (R2WA) Stock Price & Analysis
R2WA Stock Chart & Stats
- Day’s Range
- EUR 0.60 - EUR 0.60
- 52-Week Range
- EUR 0.38 - EUR 0.79
- Previous Close
- EUR 0.60
- Volume
- N/A
- Average Volume (3M)
- 670
- Market Cap
- EUR 66.74B
- Enterprise Value
- EUR 229.05M
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- 4.5
- Beta
- 0.22
- Next Earnings
- Feb 02, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 7.52%
Beximco Pharmaceuticals Limited Sponsored GDR RegS News
R2WA FAQ
What was Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price range in the past 12 months?
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap?
When is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date?
How were Beximco Pharmaceuticals Limited Sponsored GDR RegS’s earnings last quarter?
Is Beximco Pharmaceuticals Limited Sponsored GDR RegS overvalued?
Does Beximco Pharmaceuticals Limited Sponsored GDR RegS pay dividends?
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate?
How many shares outstanding does Beximco Pharmaceuticals Limited Sponsored GDR RegS have?
What happened to Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Beximco Pharmaceuticals Limited Sponsored GDR RegS?
What is the TipRanks Smart Score and how is it calculated?
Beximco Pharmaceuticals Limited Sponsored GDR RegS Stock Smart Score
Company Description
Beximco Pharmaceuticals Limited Sponsored GDR RegS
Established in 1976 and headquartered in Dhaka, Bangladesh, Beximco Pharmaceuticals Limited is a prominent company engaged in the production and distribution of generic pharmaceutical formulations and active pharmaceutical ingredients (APIs). The firm’s extensive product line addresses a wide range of therapeutic areas, including treatments for allergic disorders, pain and fever, various infections (antibacterial and antiviral), cardiovascular conditions, central nervous system ailments, respiratory illnesses, endocrine disorders, diabetes, gastrointestinal problems, hormonal therapies, oncology, musculoskeletal issues, and skin conditions. Its offerings also encompass eye care products, vitamin and mineral supplements, and intravenous fluids. These medications are supplied in a comprehensive array of dosage forms, such as solids, liquids, creams, ointments, suppositories, metered-dose and dry powder inhalers, nasal sprays, sterile injectables (including lyophilized forms), and large volume intravenous fluids. Beyond its own diverse portfolio, Beximco Pharmaceuticals provides contract manufacturing services to other companies and actively exports its products internationally.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Iqbal U. Ahmed
- Employees
- 6,000
- Website
- www.beximcopharma.com
- Address
- 19 Dhanmondi R/A, Dhaka, DA, 1205, BD
Beximco Pharmaceuticals Limited Sponsored GDR RegS (R2WA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 3 | 7 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 7 | 0 | 5 |








